All News

2070 articles, sorted by publication time.

AI Drug Discovery · global

Anthropic Moves From Scientific Workbench to In-House Drug Development, Pushing the Boundaries of Responsibility in AI Drug Discovery Further to the Front Line

Claude Science is not just letting researchers use AI to organize data and run analyses; Anthropic is now hinting that it wants to step directly into candidate drug development, shifting technology companies’ role in life sciences from tool providers to participants that are harder to treat as bystanders.

Biomedicine · global

After FDA Approval of TREGZI, Blood Cancer Transplantation Faces a More Refined Test of Immune Engineering

The significance of this approval lies not only in the addition of another transplant product, but in pushing allogeneic hematopoietic stem cell transplantation from “replacing the hematopoietic system” toward “reprogramming immune composition”; the real answers will emerge through clinical use, manufacturing consistency, and long-term follow-up.

Biotechnology · global

Pan-Cancer AI Model Targets Immunotherapy Challenge, as BioCOMPASS Tries to Put Biomarkers at the Core of Prediction

Immune checkpoint inhibitors have changed cancer treatment, yet it remains difficult to predict in advance who will benefit. The new BioCOMPASS model calibrates predictions using multiple biomarkers and treatment information. Initial data show improved accuracy, but validation hurdles remain before it can become a clinical decision-making tool.